In the last year, several cancers have been the subject of debate regarding whether the label of “cancer” should be applied to them. In 2024, low-risk prostate cancer entered the spotlight as a ...

The FDA approved updated labeling for Talzenna plus Xtandi for HRR gene-mutated metastatic castration-resistant prostate cancer, based on the TALAPRO-2 trial results. The TALAPRO-2 trial showed a ...

Medicare covers screenings and treatment for prostate cancer, with Part A covering hospital care and Part B covering outpatient care and outpatient cancer medications. Original Medicare (parts A and B ...

Former President Joe Biden's office announced Sunday that he has been diagnosed with an "aggressive" form of prostate cancer, which has spread to his bones. But it said the cancer appears to be ...